Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société FRESENIUS SE & CO. KGAA
05/11FRESENIUS  : 2020 TCFD Index (PDF, 158 KB)
PU
05/10FRESENIUS  : Conference Call Q1 2021, Fresenius (PDF, 1.87 MB)
PU
05/07FRESENIUS  : Quarterly Financial Report (PDF)
PU
05/07FRESENIUS  : Quarterly Financial Report Q1 2021 (IFRS) (PDF, 0.60 MB)
PU
05/07FRESENIUS  : Statement of the Management on the countermotion (PDF, 90 KB)
PU
05/06FRESENIUS  : with good start to 2021 despite ongoing COVID-19 impact
PU
04/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
04/26FRESENIUS  : Chairman Letter (PDF, 478 KB)
PU
04/22FRESENIUS  : Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride..
AQ
04/16FRESENIUS  : 2020 SASB Mapping (PDF, 144 KB)
PU
04/07FRESENIUS SE & CO. KGAA : Announcement of the Convening of the General Meeting ..
EQ
03/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
03/24FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
03/18FRESENIUS  : Annual Report 2020 (IFRS) (PDF, 9.98 MB)
PU
03/18FRESENIUS  : Participations in affiliated and associated companies (PDF, 0.85 MB..
PU
03/16FRESENIUS  : Michael Sen to succeed Mats Henriksson as CEO of Fresenius Kabi
PU
03/15FRESENIUS  : Kabi launches IV Drug in the U.S.
PU
02/25FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
02/24FRESENIUS  : wins tenth consecutive Potentialpark award for Germany's best onlin..
PU
02/23FRESENIUS  : achieves 2020 targets and expects healthy business development in 2..
PU
02/16FRESENIUS  : Kabi Oncology Ltd to pay $50mn for destroying records ahead of an F..
AQ
02/10FRESENIUS  : German drug firm to pay $50M in US purity case at India site
AQ
02/09FRESENIUS  : Kabi India reaches resolution to conclude 2013 Kalyani investigatio..
PU
02/09FRESENIUS  : Kabi expands facilities in Austria
PU
02/05FRESENIUS SE & CO. KGAA : Release according to Article 50 of the WpHG [the Germa..
EQ
02/01FRESENIUS  : achieves FY/20 guidance, targets healthy sales growth and at least ..
PU
02/01FRESENIUS SE & CO. KGAA : Excess mortality of dialysis patients impacts Group ne..
EQ
02/01FRESENIUS  : Medical Care anticipates significant negative COVID-19 impact on 20..
PU
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS  : Helios acquires fertility services provider Eugin Group
PU
2020FRESENIUS  : Medical Care improves in climate and water ranking
PU
2020FRESENIUS  : improves in climate ranking
PU
2020FRESENIUS  : Kabi launches IV Drug in the U.S.
PU
2020FRESENIUS  : Kabi launches its first specialty IV drug in the U.S.
PU
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
2020FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
2020FRESENIUS  : Medical Care continues solid revenue and strong earnings growth in ..
PU
2020FRESENIUS  : announces changes to Supervisory Board
PU
2020FRESENIUS  : Medical Care gets FDA approval for Biofine® PD solution bags
PU
2020FRESENIUS  : Kabi launches its first RFID smart-labeled product in the U.S.
PU
2020FRESENIUS  : Medical Care presents new strategy and announces new medium-term ta..
PU
2020FRESENIUS  : Helios enters healthcare agreement with hotel operator in Spain
PU
2020FRESENIUS  : Medical Care partners with Applied Health Signals company Livongo i..
PU
2020FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
2020FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
2020FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
2020FRESENIUS  : 2021 DRG inflator for German hospitals set at 2.53%
PU
2020FRESENIUS  : Medical Care to issue bonds with a volume of 1 billion US-dollars
PU
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
2020ANNUAL GENERAL MEETING : Stable business model proves its strength; 27th consecu..
PU
2020FRESENIUS  : acquires Malteser hospitals in German state of North Rhine-Westphal..
PU
2020FRESENIUS  : Kabi Introduces RFID Smart Labels for Medications in the U.S.
PU
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
2020FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
2020FRESENIUS  : Quarterly Financial Report Q2 2020 (IFRS)
PU
2020FRESENIUS  : with solid H1 results – Accelerated earnings growth expected ..
PU
2020FRESENIUS  : Curalie cooperates with ‘Wir für Gesundheit‘ and Debeka
PU
2020FRESENIUS SE & CO. KGAA : Announcement of the Convening of the General Meeting ..
EQ
2020FRESENIUS  : Helios publishes sustainability report
PU
2020FRESENIUS  : holds virtual General Meeting on August 28, 2020 – dividend p..
PU
2020FRESENIUS  : Medical Care holds virtual General Meeting on August 27, 2020 &ndas..
PU
2020FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
2020FRESENIUS  : Dr. Sebastian Biedenkopf to succeed Dr. Jürgen Götz on Management B..
PU
2020FRESENIUS  : Drug from Fresenius Kabi now available in the U.S. after Emergency ..
PU
2020FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
2020FRESENIUS  : Helios acquires hospital in western Germany
PU
2020FRESENIUS  : FDA accepts for review Fresenius Kabi's first biosimilar regulatory..
AQ
2020FRESENIUS  : Kabi enters marketing agreement for biosimilar product
PU
2020FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
1  2  3  4  5Next
Upcoming event on FRESENIUS SE & CO. KGAA
05/21/21